Detection of Mutations in <i>pncA</i> in <i>Mycobacterium tuberculosis</i> Clinical Isolates from Nepal in Association with Pyrazinamide Resistance

Detection of Mutations in <i>pncA</i> in <i>Mycobacterium tuberculosis</i> Clinical Isolates from Nepal in Association with Pyrazinamide Resistance

Without the proper information on pyrazinamide (PZA) susceptibility of <i>Mycobacterium tuberculosis</i> (MTB), PZA is inappropriately recommended for the treatment of both susceptible and multidrug-resistant tuberculosis (MDR-TB) in Nepal. This study aimed to collect information regardi...

Full description

Bibliographic Details
Main Authors:	Dipti Shrestha, Bhagwan Maharjan, Jeewan Thapa, Mwangala Lonah Akapelwa, Precious Bwalya, Joseph Yamweka Chizimu, Chie Nakajima, Yasuhiko Suzuki
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Series:	Current Issues in Molecular Biology
Subjects:	pyrazinamide <i>pncA</i> URR mutation <i>Mycobacterium tuberculosis</i>
Online Access:	https://www.mdpi.com/1467-3045/44/9/283

Similar Items

Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia
by: Sarah Sengstake, et al.
Published: (2017-07-01)

Biphasic Medium Using Nicotinamide for Detection of Pyrazinamide Resistance in <i>Mycobacterium tuberculosis</i>
by: Waraporn Thuansuwan, et al.
Published: (2024-06-01)

Analysis of pncA gene expression in pyrazinamide-resistant and multidrug-resistant <i>Mycobacterium tuberculosis</i>
by: Wang Nan，, Yang Yu, Deng Ling, Wu Hui, Liu Zhihui, Meng Fanrong
Published: (2023-12-01)

Characterization of pncA Mutations and Prediction of PZA Resistance in Mycobacterium tuberculosis Clinical Isolates From Chongqing, China
by: Kun Li, et al.
Published: (2021-01-01)

Resistance To First-Line Antituberculosis Drugs And Prevalence Of pncA Mutations In Clinical Isolates Of Mycobacterium tuberculosis From Zunyi, Guizhou Province Of China
by: Cao Z, et al.
Published: (2019-09-01)

Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates<subtitle>PncA mutations and PZA resistance in M. tuberculosis in Vietnam</subtitle>
by: Nguyen Quang Huy, et al.
Published: (2017-01-01)

Estimation of pyrazinamidase activity using a cell-free In vitro synthesis of pnca and its association with pyrazinamide susceptibility in Mycobacterium tuberculosis
by: Daniel Rueda, et al.
Published: (2018-01-01)

Characterization of pyrazinamide resistance in consecutive multidrug-resistant mycobacterium tuberculosis isolates in sweden between 2003 and 2015
by: Mikael Mansjo, et al.
Published: (2017-01-01)

The epidemiology and gene mutation characteristics of pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates in Southern China
by: Nan Wang, et al.
Published: (2025-12-01)

The majority of patients with multidrug-resistant tuberculosis in Sub-Saharan Africa present a concomitant resistance to pyrazinamide
by: Géraldine Daneau, et al.
Published: (2016-01-01)

‘ZS-MDR-TB’ versus ‘ZR-MDR-TB’: improving treatment of MDR-TB by identifying pyrazinamide susceptibility
by: Ying Zhang, et al.
Published: (2012-07-01)

Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium Tuberculosis
by: Shi D, et al.
Published: (2022-08-01)

Pyrazinamide resistance in Swedish multidrug-resistant tuberculosis 2003–2013
by: M Mansjö, et al.
Published: (2015-01-01)

Exploring of pyrazinamidase recombinant activity from PZA-sensitive and resistant Mycobacterium tuberculosis expressed in Escherichia coli BL21 (DE3)
by: P. Purkan, et al.
Published: (2024-02-01)

The Study of PncA Gene Using PCR-RFLP and Allele-Specific PCR Methods in Distinguishing Mycobacterium Bovis from Mycobacterium Tuberculosis
by: Mohammad Reza Allahyar Torkaman, et al.
Published: (2011-12-01)

Next-generation sequencing to characterise pyrazinamide resistance in Mycobacterium tuberculosis isolates from two Balkan countries
by: Eva Sodja, et al.
Published: (2022-06-01)

Novel Mutations in pncA Gene of Pyrazinamide Resistant Clinical Isolates of Mycobacterium tuberculosis
by: Manijeh Kahbazi, et al.
Published: (2018-04-01)

Molecular Identification of Mutations Associated with Pyrazinamide-Resistance in Multidrug-Resistant Tuberculosis in Eight Provinces of Iran
by: Jila Moradi, et al.
Published: (2017-11-01)

pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia
by: Salim Allana, et al.
Published: (2017-03-01)

Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China
by: Yang Che, et al.
Published: (2021-06-01)

Pyrazinamide Resistance and Mutation Patterns Among Multidrug-Resistant Mycobacterium tuberculosis from Henan Province
by: Shi J, et al.
Published: (2020-08-01)

Activity of Pyrazinamide against <i>Mycobacterium tuberculosis</i> at Neutral pH in PZA-S1 Minimal Medium
by: Wanliang Shi
Published: (2021-07-01)

Pyrazinamide-induced maculopapular rash
by: Khayyam Khalid, et al.
Published: (2010-01-01)

Prevalence, Transmission and Genetic Diversity of Pyrazinamide Resistance Among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Hunan, China
by: Liu B, et al.
Published: (2024-02-01)

Genetic Diversity and Drug Susceptibility Profiles of Multidrug-Resistant Tuberculosis Strains in Southeast China
by: Lin S, et al.
Published: (2021-09-01)

Multidrug-resistant Myobacterium tuberculosis caused by the Beijing genotype and a specific T1 genotype clone (SIT No. 266) is widely transmitted in Minsk
by: Aksana Zalutskaya, et al.
Published: (2013-01-01)

Characterization of Mutations Associated with Streptomycin Resistance in Multidrug-Resistant <i>Mycobacterium tuberculosis</i> in Zambia
by: Precious Bwalya, et al.
Published: (2021-09-01)

A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide
by: Adam N. Yadon, et al.
Published: (2017-09-01)

Synthesis, Biological Evaluation, and In Silico Modeling of <i>N</i>-Substituted Quinoxaline-2-Carboxamides
by: Ghada Bouz, et al.
Published: (2021-08-01)

Substituted <i>N</i>-(Pyrazin-2-yl)benzenesulfonamides; Synthesis, Anti-Infective Evaluation, Cytotoxicity, and In Silico Studies
by: Ghada Bouz, et al.
Published: (2019-12-01)

Whole-Genome Sequencing Reveals Recent Transmission of Multidrug-Resistant <i>Mycobacterium tuberculosis</i> CAS1-Kili Strains in Lusaka, Zambia
by: Joseph Yamweka Chizimu, et al.
Published: (2021-12-01)

Pyrazinoic Acid Inhibits the Bifunctional Enzyme (Rv2783) in <i>Mycobacterium tuberculosis</i> by Competing with tmRNA
by: Lei He, et al.
Published: (2019-11-01)

New insights into the mechanism of action of pyrazinamide, implications for susceptibility testing, and future regimens*
by: Richard M Anthony, et al.
Published: (2016-01-01)

Pyrazinamide-induced phototoxicity: A case report and review of literature
by: Katiyar Subodh, et al.
Published: (2010-01-01)

O SURGIMENTO DOS CENTROS DE DOCUMENTAÇÃO UNIVERSITÁRIOS E SUA RELAÇÃO COM A PNC DE 1975
by: Marcia Teixeira Cavalcanti
Published: (2019-10-01)

Pyrazinamide-induced Hyperuricemia in Pulmonary Tuberculosis Patients
by: Oki Nugraha Putra, et al.
Published: (2024-09-01)

Relationship between sensitivity and annoyance with noise parameters (PNC, SIL) in hospitals of Behbahan
by: Zahra Hashemi, et al.
Published: (2016-08-01)

Nigella sativa can Cure Hepatotoxicity Caused by Pyrazinamide Administration; A Lead from Animal Experiment
by: Amtul Hafeez, et al.
Published: (2020-12-01)

Genomic Analysis of <i>Mycobacterium tuberculosis</i> Strains Resistant to Second-Line Anti-Tuberculosis Drugs in Lusaka, Zambia
by: Joseph Yamweka Chizimu, et al.
Published: (2023-06-01)

High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda.
by: Resty Naluyange, et al.
Published: (2020-01-01)